Reliance Global Group Inc.

11/16/2026 | Press release | Distributed by Public on 11/16/2026 16:19

Quarterly Report for Quarter Ending September 30, 2026 (Form 10-Q)

Management's Discussion and Analysis of Financial Condition and Results of Operations

You should read the following discussion and analysis of our financial condition and results of operations together with our unaudited condensed consolidated financial statements and the related notes included elsewhere in this Quarterly Report on Form 10-Q, as well as the audited consolidated financial statements and related notes included in our Annual Report on Form 10-K for the year ended December 31, 2025 (the "Annual Report"). Some of the information contained in this discussion and analysis or set forth elsewhere in this Quarterly Report on Form 10-Q, including information with respect to our plans and strategy for our business and related financing, includes forward-looking statements that involve risks, uncertainties and assumptions. You should read the sections titled "Cautionary Note Regarding Forward-Looking Statements" and "Risk Factors" in this Quarterly Report on Form 10-Q and in our Annual Report for a discussion of important factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis.

Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact contained in this report-including statements regarding our strategy (including our digital-asset treasury strategy and related blockchain/tokenization initiatives), our acquisition of the Oblivus GPU cloud computing business and our plans to expand our GPU computing capacity and marketplace operations under the GPU Exchange brand, future financial condition, liquidity and capital resources, future operations, projected revenues, earnings (losses), margins, cash flows, business prospects, potential acquisitions and integration, and plans and objectives of management-are forward-looking statements.

Words such as "anticipates," "believes," "could," "estimates," "expects," "forecasts," "guidance," "intends," "may," "might," "outlook," "plans," "potential," "predicts," "projects," "seeks," "should," "targets," "will," "would," and similar expressions (and negative forms of such words) are intended to identify forward-looking statements. These statements are based on current expectations and assumptions and are subject to risks and uncertainties that may cause actual results to differ materially, including, but not limited to:

● our need to raise additional capital, which may not be available on acceptable terms or at all;
● our ability to satisfy and maintain compliance with The Nasdaq Capital Market's continued listing standards, including the $1.00 minimum bid price requirement; and, if it becomes effective, the $5.0 million minimum Market Value of Listed Securities ("MVLS") requirement;
● our ability to maintain the listing of our common stock on the Nasdaq Capital Market;
● volatility in the price of our securities due to changes in the capital markets, our industry, or our capital structure;
● our ability to execute on our acquisition strategy and integrate acquired businesses successfully;
● our ability to retain key personnel and effectively manage growth;
● the risk that we and our agency partners are unable to generate expected revenues or margins;
● risks associated with the insurance brokerage industry, including carrier concentration, regulation, competition, and cyclicality;
● the impact of economic conditions, inflation, and interest rate trends on our operations and customer demand;
● our ability to successfully integrate and operate the Oblivus GPU cloud computing business, a line of business in which we have limited operating experience and our ability to achieve the revenue and growth we expect from that business or obtain the capital required to expand our GPU capacity;
● risks associated with our recently announced expansion into the technology sector through our EZRA International Group platform and our Scale51 operating model, including our ability to identify, complete, and integrate investments in technology-driven businesses and the risk of further losses such as the loss of our investment in Enquantum;
● risks associated with our recent expansion into the life sciences sector through LifeSci Global Group LLC, including the speculative nature of early-stage life sciences investments including its investment in Innervate, and conflicts of interest with our directors and officers;
● potential disruptions due to cybersecurity incidents or system failures;
● risks associated with legal proceedings and compliance obligations;and
● other risks and uncertainties described in this Quarterly Report on Form 10-Q (including under "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations") and in our other filings with the Securities and Exchange Commission.

Forward-looking statements speak only as of the date of this Quarterly Report on Form 10-Q. Except as required by applicable law, we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. All forward-looking statements are expressly qualified in their entirety by this cautionary note.

Overview

Reliance Global Group, Inc. (the "Company") is a diversified company engaged in insurance brokerage, InsurTech, and technology-related businesses. During the nine months ended September 30, 2026, the Company's primary operations consisted of its insurance brokerage businesses and proprietary technology platforms, including RELI Exchange and 5MinuteInsure.com. Subsequent to September 30, 2026, the Company expanded into the GPU cloud computing and artificial intelligence infrastructure sector through its acquisition of Oblivus, as further described under Recent Developments. The Company intends to develop its GPU computing operations while continuing to operate its existing insurance and InsurTech businesses.

Recent Developments

Nasdaq Ticker Symbol Change and GPU Exchange Branding

On November 9, 2026, the Company announced that its ticker symbol on The Nasdaq Capital Market would change from "EZRA" to "XGPU," effective at the open of trading on November 10, 2026. The ticker symbol change reflects the Company's expansion into the GPU cloud computing and artificial intelligence ("AI") infrastructure market following its acquisition of the assets of Oblivus on November 3, 2026.

In connection with this strategic expansion, the Company is adopting "GPU Exchange" as its doing-business-as name, and the acquired Oblivus business will operate under the GPU Exchange brand. The Company's legal name will remain Reliance Global Group, Inc., and its common stock will continue to be listed on The Nasdaq Capital Market under the new ticker symbol, with no change to its CUSIP number.

The Company intends to focus on expanding its GPU computing capacity and marketplace operations while continuing to operate and develop its RELI Exchange InsurTech platform.

Acquisition of Oblivus

On November 3, 2026, the Company, through its wholly owned subsidiary GPU Exchange Corp., completed the acquisition of the assets of Oblivus, a GPU cloud computing platform and marketplace, from Skyportal Inc. for cash consideration of $3.0 million, plus up to an additional $750,000 contingent upon the achievement of specified revenue milestones over the following twelve months. Of the contingent consideration, $375,000 was deposited into escrow at closing.

In connection with the acquisition, the Company entered into a twelve-month consulting agreement with Oblivus's founder, providing for cash compensation of $250,000 and potential stock awards valued at up to $600,000, subject to Board approval and certain conditions. The acquisition represents an expansion of the Company's technology operations into the GPU cloud computing sector and supports its strategy of pursuing growth opportunities beyond its traditional insurance brokerage operations.

Cash Settlement of Certain Equity Awards

On October 19, 2026, our Compensation Committee approved cash payments totaling $788,923.97, in lieu of shares, in settlement of unissued balances of equity awards approved on June 24, 2026 for our Chairman and Chief Executive Officer, our Chief Operating Officer and a Vice President (two of whom are related to directors or officers). See Note 14 to the unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for additional information.

Sale of UIS Agency LLC

On October 13, 2026, the Company completed the sale of 100% of its ownership interests in UIS Agency LLC ("UIS"), a wholly owned insurance brokerage subsidiary, for cash consideration of $120,000. As of September 30, 2026, the Company had classified the assets of UIS as held for sale and recognized an impairment loss of approximately $91,000 during the third quarter of 2026. The Company expects to recognize an additional loss upon completion of the sale in the fourth quarter of 2026, subject to final closing adjustments.

Business Operations

Repayment of Oak Street Funding Loan

During the third quarter of 2026, the Company fully repaid its outstanding term loan with Oak Street Funding LLC, which was originally entered into in connection with the acquisition of Barra & Associates, LLC. In connection with the repayment, the Company recognized a loss on extinguishment of debt of approximately $118,000, primarily related to the write-off of unamortized deferred financing costs. As of September 30, 2026, no amounts remained outstanding under the loan. The repayment reduced the Company's outstanding indebtedness and future interest obligations.

Sale of Southwestern Montana Insurance Center

Effective September 1, 2026, the Company completed the sale of 100% of its ownership interests in Southwestern Montana Insurance Center, LLC ("SWM") for consideration of approximately $2.6 million, together with additional contingent consideration based on future operating performance. In connection with the sale, the Company recognized a gain of approximately $1.9 million during the third quarter of 2026.

Sale of Altruis Benefit Consultants

In September 2026, the Company completed the sale of substantially all the operating assets of Altruis Benefit Consultants, Inc. ("Altruis") for aggregate consideration of $8.0 million, subject to certain working capital adjustments and including cash consideration, a secured promissory note and certain holdbacks. The Company may also receive additional contingent consideration of up to $1.0 million based on future revenue growth. In connection with the sale, the Company recognized a gain of approximately $5.8 million during the third quarter of 2026.

Equity Investments

During the first quarter of 2026, the Company, through its Scale51 operating model, and EZRA International Group ("EIG"), pursued selected strategic equity investments in technology and healthcare-related businesses. During the second quarter of 2026, management reassessed its strategic priorities and capital allocation objectives and reduced its level of Scale51 activity while selectively evaluating future investment opportunities.

Enquantum

The Company invested approximately $0.8 million in Enquantum Ltd., a cybersecurity company, during 2026. Following Enquantum's cessation of operations during the third quarter, and considering its financial condition, lack of committed funding and limited recovery prospects, the Company recognized a non-cash impairment charge of approximately $0.7 million, reducing the investment's carrying value to zero. Including approximately $0.1 million of equity method losses recognized earlier in the year, total investment-related losses were approximately $0.8 million for the nine months ended September 30, 2026. The Company retains its ownership interest, has no obligation to fund additional amounts under the Share Purchase Agreement and continues to evaluate its rights and remedies under that agreement.

LGG and Investment in Innervate

In April 2026, the Company formed LifeSci Global Group LLC ("LGG") as a platform for healthcare and life sciences investments. The Company owns approximately 51% of LGG through its wholly owned subsidiary EZRA International Group, LLC ("EIG"). The remaining interest is held by an entity affiliated with certain members of management and the Board of Directors. LGG entered into an agreement to invest up to approximately $2.0 million in Innervate Radiopharmaceuticals LLC ("Innervate"), an early-stage life sciences company, with funding payable in installments at LGG's discretion. As of September 30, 2026, LGG had invested $0.95 million and held an approximately 1.05% ownership interest in Innervate. Subsequent to quarter-end, LGG invested approximately an additional $0.23 million, bringing its aggregate investment to approximately $1.18 million. A Company director serves as Innervate's chief executive officer. The related-party arrangements were reviewed and approved by the independent and disinterested members of the Company's Board of Directors.

Scentech Transaction

During the second quarter of 2026, the Company determined not to proceed with its previously disclosed proposed acquisition of an interest in Scentech Medical Ltd. No definitive agreement was executed, and the parties did not reach final terms. The Company has not incurred any termination fees or other material liabilities in connection with the discontinuation of those discussions.

Digital Asset Treasury Strategy

In September 2025, the Company adopted a digital asset treasury strategy contemplating the allocation of a portion of its treasury assets to cryptocurrencies and related blockchain initiatives. The Company held digital assets as of December 31, 2025, but held no digital assets as of September 30, 2026. The Company has scaled back this initiative, which is currently on hold, while continuing to evaluate other capital deployment opportunities, including operating investments and strategic acquisitions. Any future digital asset holdings would be subject to market price volatility, which could affect results of operations.

Capital Markets Activity

In January 2026, the Company completed a public offering that generated gross proceeds of approximately $2.0 million, enhancing liquidity and capital resources. The offering consisted of common stock and accompanying warrants, and during the nine months ended September 30, 2026, the Company received approximately $0.8 million from the exercise of outstanding warrants.

In February 2026, the Company amended its at-the-market ("ATM") offering program, increasing the aggregate amount of common stock that may be offered and sold from time to time to approximately $1.8 million. The ATM program provides the Company with additional flexibility to access capital as needed, subject to market conditions. During the nine months ended September 30, 2026, the Company sold shares under its ATM program for combined net proceeds of approximately $1.7 million, with only a de minimis amount remaining available under the program for future issuances.

In March 2026, the Company also amended its equity line of credit facility, extending the availability period through December 31, 2028 (subject to earlier utilization) and increasing the total committed capital to $50.0 million. During the nine months ended September 30, 2026, the Company sold shares under the facility for aggregate net proceeds of approximately $720,000, with approximately $48.3 million of remaining capacity as of September 30, 2026, subject to the terms of the facility.

These financing activities strengthened the Company's liquidity and expanded its financing capacity to support ongoing operations, strategic acquisitions and other corporate purposes.

Stockholder Rights Plan

On September 3, 2026, the Company announced that its Board of Directors adopted a one-year stockholder rights plan intended to protect stockholder interests against certain unsolicited takeover attempts. The rights generally become exercisable if a person or group acquires 15% or more of the Company's outstanding common stock without Board approval, subject to certain exceptions. The plan is scheduled to expire on September 3, 2027, unless earlier redeemed or terminated by the Board.

Settlement Agreements

During March 2026, the Company entered into settlement agreements related to certain prior stock purchase transactions and matters involving previously asserted guarantees, including those associated with related parties. In connection with these agreements, the Company paid aggregate settlement amounts of approximately $131,000. The settlements were reviewed and approved by the independent members of the Company's Board of Directors.

Amendment to 2025 Equity Incentive Plan

On May 6, 2026, the Company's stockholders approved an amendment to the Company's 2025 Equity Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 350,000 shares, from 50,000 shares to 400,000 shares. The amendment was approved at the Company's 2026 Annual Meeting of Stockholders and is intended to support the Company's ongoing employee, director, consultant, and strategic incentive compensation programs.

Reverse Stock Split

On May 7, 2026, our Board of Directors approved a 1-for-40 reverse stock split of our issued and outstanding common stock, as well as a proportional reduction in the number of authorized shares of common stock. The reverse stock split became effective for trading purposes on May 18, 2026.

The reverse stock split was undertaken to increase the market price of our common stock and to enable us to regain compliance with the $1.00 minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). On June 2, 2026, we received a letter from the Nasdaq Listing Qualifications Department notifying us that we had regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2), and that the matter is now closed.

As a result of the reverse stock split, every 40 shares of our outstanding common stock were automatically combined into one share of common stock, and the number of authorized shares of common stock was reduced proportionately. Unless otherwise indicated, all share and per-share amounts relating to the Company's common stock in this Quarterly Report on Form 10-Q have been retroactively adjusted to reflect the 1-for-40 reverse stock split for all periods presented. The reverse stock split did not affect stockholders' relative ownership interests, except with respect to the treatment of fractional shares. As a result of the reverse stock split, the CUSIP number assigned to the Company's common stock was changed to 75946W504.

While the reverse stock split increased the per share trading price of our common stock, there can be no assurance that we will continue to meet Nasdaq's continued listing standards in the future. We continue to monitor our stock price and may take additional actions, if necessary, to maintain compliance with applicable listing requirements.

Corporate Governance

On March 11, 2026, the Company adopted Amended and Restated Bylaws, which, among other things, revised the provision relating to the timing of the annual meeting of stockholders so that the date, time and place of the annual meeting may be determined by the Company's Board of Directors. On March 17, 2026, the Company filed Articles of Restatement with the Florida Department of State, restating the Company's Articles of Incorporation in their entirety.

Business Trends and Uncertainties

The insurance intermediary business is highly competitive, and we actively compete with numerous firms for customers and insurance companies, many of which have relationships with insurance companies, or have a significant presence in niche insurance markets that may give them an advantage over us. Other competitive concerns may include the quality of our products and services, our pricing and the ability of some of our customers to self-insure and the entrance of technology companies into the insurance intermediary business. Several insurance companies are engaged in the direct sale of insurance, primarily to individuals, and do not pay commissions to agents and brokers.

Insurance Operations

Our insurance operations focus on growing RELI Exchange and expanding insurance distribution through our agency partner network and other distribution relationships. RELI Exchange provides independent agency partners with access to insurance carriers, technology and centralized operational support to help them place and service insurance policies. Our agencies generate commission revenue from new and renewal policies placed with third-party insurance carriers, which assume the underwriting risk.

Our growth priorities include recruiting additional agency partners, increasing production across our existing network, expanding distribution partnerships and broadening available insurance products. We continue to develop automation and artificial intelligence capabilities to streamline quoting, policy servicing and administrative functions, with the objective of supporting higher policy volumes while improving operating efficiency and customer service.

We also evaluate selective acquisitions and other strategic opportunities that complement our insurance platform and are consistent with our capital allocation priorities.

Insurance Agency Portfolio

Our insurance operations include RELI Exchange and Kush Benefit Solutions. During 2025, the Company sold U.S. Benefits Alliance ("USBA"), Employee Benefits Solutions ("EBS") and Fortman Insurance Services ("FIS"). During the third quarter of 2026, the Company sold Altruis Benefit Consultants ("ABC") and Southwestern Montana Insurance Center ("SWM"). UIS Agency ("UIS"), including Commercial Coverage Solutions, was classified as held for sale at September 30, 2026 and subsequently sold on October 13, 2026.

For the nine months ended September 30, 2026, ABC, SWM and UIS contributed commission revenue of approximately $4.09 million, $1.06 million and $161,000, respectively, totaling approximately $5.31 million. For the third quarter of 2026, these businesses contributed combined commission revenue of approximately $1.05 million. The results of these businesses are included in consolidated results through their respective disposal dates. Their absence following disposal will affect future revenue and expense comparisons.

The Company continues to develop its retained insurance operations through RELI Exchange's agency partner network, distribution relationships and technology capabilities.


Non-GAAP Financial Measure

The Company believes certain financial measures which meet the definition of non-GAAP financial measures, as defined in Regulation G of the SEC rules, provide important supplemental information. Adjusted EBITDA ("AEBITDA"), our key financial performance metric, is a non-GAAP financial measure that is not in accordance with, or an alternative to, measures prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP"). "AEBITDA" is defined as earnings before interest, taxes, depreciation, and amortization (EBITDA) with additional adjustments as further outlined below. The Company considers AEBITDA an important financial metric because it provides a meaningful financial measure of the quality of the Company's operational, cash impacted and recurring earnings and operating performance across reporting periods. Other companies may calculate Adjusted EBITDA differently than we do, which might limit its usefulness as a comparative measure to other companies in the industry. AEBITDA is used by management in addition to and in conjunction (and not as a substitute) with the results presented in accordance with GAAP. Management uses AEBITDA to evaluate the Company's operational performance, including earnings across reporting periods and the merits for implementing cost-cutting measures. We have presented AEBITDA solely as supplemental disclosure because we believe it allows for a more complete analysis of results of operations and assists investors and analysts in comparing our operating performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. Consistent with Regulation G, a description of such information is provided below herein and tabular reconciliations of this supplemental non-GAAP financial information to our most comparable GAAP information are contained in this Quarterly Report on Form 10-Q under "Results of Operations".

We exclude the following items when calculating AEBITDA, and the following items define our non-GAAP financial measure AEBITDA:

● Interest and related party interest expense: Unrelated to core Company operations and excluded to provide more meaningful supplemental information regarding the Company's core operational performance.
● Depreciation and amortization: Non-cash charge, excluded to provide more meaningful supplemental information regarding the Company's core operational performance.
● Goodwill and/or asset impairments: Non-cash charge, excluded to provide more meaningful supplemental information regarding the Company's core operational performance.
● Equity-based compensation: Non-cash compensation provided to employees and service providers, (including period amortization cost of service provider prepaid expenses that were prepaid with stock) excluded to provide more meaningful supplemental information regarding the Company's core cash impacted operational performance.
● Other income (expense), net and/or Settlement income: Includes income and expenses unrelated to the Company's core operations, such as proceeds from the settlement of an arbitration involving a divested business, and other individually de minimis items, excluded to provide more meaningful supplemental information regarding the Company's core operational performance. Charitable contributions, which are also included in other (income) expense, net, are not excluded.
● Gain (Loss) from Equity Method Investment: Includes certain gains and losses on equity method investments that are non-cash, and thus excluded to provide more meaningful supplemental information regarding the Company's core operational performance.
● Unrealized gains (losses) on digital assets, net: This account includes unrealized gains and losses from digital assets and is thus excluded as unrelated to core operations of the company.
● Gain on sale: This account includes gains on sale from certain agency divestitures that occurred in the period which are unrelated to primary Company operations and are excluded to provide more meaningful supplemental information regarding the Company's core operational performance.
● Loss on Extinguishment of debt: Non-cash write-off of unamortized debt issuance costs upon the repayment of the Company's term debt, excluded to provide more meaningful supplemental information regarding the Company's core operational performance.
●

Equity investments impairment loss: Non-cash charge to reduce the carrying value of an equity investment to its estimated fair value, excluded to provide more meaningful supplemental information regarding the Company's core operational performance.

● Transactional costs: This includes expenses related to mergers, acquisitions, financings and refinancings, and amendments or modification to indebtedness. These costs are unrelated to primary Company operations and are excluded to provide more meaningful supplemental information regarding the Company's core operational performance.
● Non-standard costs: This account includes non-recurring non-operational items, related to costs incurred for a legal suit the Company has filed against one of the third parties involved in previously discontinued operations and was excluded to provide more meaningful supplemental information regarding the Company's core operational performance.

Refer to the reconciliation of net (loss) income to AEBITDA, illustrated below in tabular format.

Results of Operations

RELIANCE GLOBAL GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS ANALYTICS

Comparison of the three months ended September 30, 2026 to the three months ended September 30, 2025

Three Months Ended
September 30, 2026 September 30, 2025 Value Fluctuation Percent Fluctuation
Commission Income $ 1,842,997 $ 2,495,975 $ (652,978 ) -26 %
Commission Expense 783,707 995,945 (212,238 ) -21 %
Salaries and wages 3,262,869 3,912,326 (649,457 ) -17 %
General and administrative expenses 948,630 1,120,776 (172,146 ) -15 %
Marketing and advertising expenses 21,870 66,917 (45,047 ) -67 %
Depreciation and amortization 216,829 313,694 (96,865 ) -31 %
Asset Impairments 90,841 - 90,841 -
Total operating expenses 5,324,747 6,409,658 (1,084,911 ) -17 %
-
Loss from operations (3,481,749 ) (3,913,683 ) 431,934 -11 %
Other income (expense)
Interest expense (127,399 ) (246,722 ) 119,323 -48 %
Interest (expense) related parties - (4,704 ) 4,704 -100 %
Other income (expense), net 51,630 (16,470 ) 68,100 -413 %
Equity investments impairment loss (713,771 ) - (713,771 ) -
Gain on sale of business 7,730,012 3,033,554 4,696,458 155 %
Gain (loss) on Extinguishment of debt (117,841 ) - (117,841 ) -
Unrealized gains (losses) on digital assets, net - (8,558 ) 8,558 -
Total other (expense) income 6,822,631 2,757,100 4,065,531 147 %
Net income (loss) 3,340,881 (1,156,583 ) 4,497,464 -
Less: Net loss attributable to non-controlling interests (6,557 ) - (6,557 ) -
Net income (loss) attributable to Reliance Global Group, Inc. $ 3,347,438 $ (1,156,583 ) $ 4,504,021 -
Non-GAAP Measure
AEBITDA $ (1,946,975 ) $ (707,021 ) $ (1,239,954 ) -

Three Months Ended September 30, 2026

Commission Income

The decrease in consolidated commission income primarily reflected the 2025 divestiture of Employee Benefits Solutions, the third-quarter 2026 divestitures of Altruis Benefit Consultants, Inc. and Southwestern Montana Insurance Center, and lower commission revenue at Kush Benefit Solutions, partially offset by growth at RELI Exchange.

Commission Expense

The decrease in consolidated commission expense primarily reflected the 2025 and 2026 divestitures and lower commission expense at Kush Benefit Solutions.

Salaries and Wages

The decrease in consolidated Salaries and Wages was primarily attributable to higher non-cash employee equity awards in the prior-year period, as well as the elimination of compensation costs associated with FIS and EBS following their divestitures, partially offset by increased compensation costs related to additional corporate personnel and compensation adjustments.

General and Administrative Expenses

The decrease in consolidated General and Administrative Expenses was primarily attributable to higher non-cash director equity awards and consulting costs in the prior-year period, partially offset by growth related costs in 2026.

Marketing and Advertising Expenses

The decrease in consolidated Marketing and Advertising Expenses reflects changes in the Company's marketing strategies and related expenditures.

Depreciation and Amortization

The decrease in consolidated Depreciation and Amortization Expense was primarily attributable to the divestitures of FIS and EBS during 2025 and the elimination of depreciation and amortization associated with the related assets.

Asset Impairments

During the three months ended September 30, 2026, the Company recognized an impairment loss of approximately $91,000 related to the reclassification of UIS Agency LLC (UIS) to assets as held for sale. No comparable impairment was recognized in the prior-year period.

Other Income (Expense)

The increase in consolidated total other income was primarily attributable to higher gains on the sales of businesses, including the divestitures of Altruis Benefit Consultants (Altruis) and Southwestern Montana Insurance Center (SWM), which generated aggregate gains of approximately $7.7 million, compared to approximately $3.0 million in the prior-year period. The increase was also attributable to lower interest expense resulting from debt repayments and higher other income primarily related to settlement income, partially offset by an impairment loss of approximately $714,000 on the Company's investment in Enquantum and a loss on extinguishment of debt of approximately $118,000.

AEBITDA

The decrease in consolidated AEBITDA was primarily attributable to lower commission revenue resulting from agency divestitures and increased cash compensation costs.

RELIANCE GLOBAL GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS ANALYTICS

Comparison of the nine months ended September 30, 2026 to the nine months ended September 30, 2025

Nine Months ended
September 30, 2026 September 30, 2025 Value Fluctuation Percent Fluctuation
Commission Income $ 7,780,604 $ 9,818,872 $ (2,038,268 ) -21 %
Commission Expense 3,192,515 3,454,147 (261,632 ) -8 %
Salaries and wages 6,443,020 8,705,682 (2,262,662 ) -26 %
General and administrative expenses 3,462,860 4,129,842 (666,982 ) -16 %
Marketing and advertising expenses 362,888 201,399 161,489 80 %
Depreciation and amortization 774,249 1,020,440 (246,191 ) -24 %
Asset Impairments 90,841 - - -
Total operating expenses 14,326,373 17,511,511 (3,185,138 ) -18 %
-
Loss from operations (6,545,769 ) (7,692,639 ) 1,146,870 -15 %
-
Other income (expense) -
Interest expense (378,444 ) (844,846 ) 466,402 -55 %
Interest (expense) related parties - (50,811 ) 50,811 -100 %
Other income (expense), net 12,363 (41,068 ) 53,431 -130 %
Gain (Loss) from Equity Method Investment (120,384 ) - (120,384 ) -
Equity investments impairment loss (713,771 ) - (713,771 ) -
Gain on sale of business 7,730,012 3,033,554 4,696,458 155 %
Gain (loss) on Extinguishment of debt (117,841 ) - (117,841 ) -
Unrealized gains (losses) on digital assets, net 9,263 (8,558 ) 17,821 -208 %
Total other (expense) income 6,421,198 2,088,271 4,332,927 207 %
Net loss (124,571 ) (5,604,367 ) 5,479,796 -98 %
Less: Net loss attributable to non-controlling interests (9,470 ) - (9,470 ) -
Net loss attributable to Reliance Global Group, Inc. $ (115,101 ) $ (5,604,367 ) $ 5,489,266 -98 %
Non-GAAP Measure
AEBITDA $ (3,519,218 ) $ (918,706 ) $ (2,600,512 ) -

Nine Months Ended September 30, 2026

Commission Income

The decrease in consolidated Commission Income was primarily attributable to the divestitures of Fortman Insurance Services (FIS) and Employee Benefit Solutions (EBS) during 2025, which eliminated commission revenue previously generated by these operations, as well as some declines in organic revenue offset by organic revenue growth in certain of our retained businesses.

Commission Expense

The decrease in consolidated Commission Expense was primarily attributable to lower commission revenue, including the impact of the divestitures of FIS and EBS during 2025.

Salaries and Wages

The decrease in consolidated Salaries and Wages was primarily attributable to higher non-cash employee equity awards in the prior-year period, as well as the elimination of compensation costs associated with FIS and EBS following their divestitures, partially offset by increased compensation costs related to additional corporate personnel and compensation adjustments.

General and Administrative Expenses

The decrease in consolidated General and Administrative Expenses was primarily attributable to higher acquisition-related share expenses and non-cash director equity awards in the prior-year period, partially offset by increased growth related legal, consulting, and investor relations costs in 2026.

Marketing and Advertising Expenses

The increase in consolidated Marketing and Advertising Expenses reflects changes in the Company's marketing strategies and related expenditures.

Depreciation and Amortization

The decrease in consolidated Depreciation and Amortization Expense was primarily attributable to the divestitures of FIS and EBS during 2025 and the elimination of depreciation and amortization associated with the related assets.

Asset Impairments

During the nine months ended September 30, 2026, the Company recognized an impairment loss of approximately $91,000 related to the reclassification of UIS Agency LLC (UIS) to assets held for sale. No comparable impairment was recognized in the prior-year period.

Other Income (Expense)

The increase in consolidated total other income was primarily attributable to higher gains on the sales of businesses, including the divestitures of Altruis Benefit Consultants (Altruis) and Southwestern Montana Insurance Center (SWM), which generated aggregate gains of approximately $7.7 million, compared to approximately $3.0 million in the prior-year period. The increase was also attributable to lower interest expense resulting from debt repayments, the repayment of related-party debt, higher settlement income, and gains on digital assets, partially offset by an impairment loss of approximately $714,000 on the Company's investment in Enquantum, a loss of approximately $120,000 from an equity method investment, and a loss on extinguishment of debt of approximately $118,000.

AEBITDA

The decrease in consolidated AEBITDA was primarily attributable to lower commission revenue reflecting the agency divestitures and declines in certain organic revenue offset by certain organic growth, as well as increased cash compensation costs.

Insurance Segment - Results of Operations

Insurance segment comparison of the three months ended September 30, 2026 to the three months ended September 30, 2025

September 30, 2026 September 30, 2025 Change % Change
Insurance Insurance
Commission income $ 1,842,997 $ 2,495,975 $ (652,978 ) -26 %
Total Revenue 1,842,997 2,495,975 (652,978 ) -26 %
Total operating expenses
Commission expense 783,707 995,945 (212,238 ) -21 %
Salaries and wages 792,917 869,538 (76,621 ) -9 %
General and administrative expenses 271,117 258,364 12,753 5 %
Marketing and advertising 3,728 8,583 (4,855 ) -57 %
Interest expense 119,693 240,491 (120,798 ) -50 %
Interest expense related parties - 4,490 (4,490 ) -100 %
Insurance Segment net income (loss) $ (128,164 ) $ 118,563 $ (246,727 ) -208 %

Insurance segment revenue decreased compared to the prior-year period. Commission Income decreased, primarily attributable to portfolio realignments completed during 2025, including the divestiture of Employee Benefits Solutions (EBS), which eliminated commission revenue previously generated by these operations as well as a decline in organic revenue from retained businesses.

Total operating expenses decreased overall compared to the prior-year period, primarily reflecting cost reductions associated with the divestiture of certain business operations and ongoing efficiency initiatives.

● Commission expense decreased, primarily attributable to the Company's portfolio realignment initiatives completed during 2025, including the divestitures of Employee Benefits Solutions (EBS), which eliminated commission expense previously incurred by these operations.
● Salaries and wages decreased significantly due to the elimination of personnel costs associated with the divested FIS and EBS businesses.
● General and administrative expenses increased due to expenses associated with the sale of Altruis, partially offset by general operational efficiencies.
● Marketing and advertising expenses decreased substantially, consistent with the Company's current marketing strategy.

Total interest expense (including related party interest) decreased due to the repayment of outstanding loan balances and periodic paydowns of related party obligations.

As a result of the above factors, the Insurance segment reported a net loss compared to net income in the prior-year period. The decline in profitability was primarily attributable to lower commission revenue following the divestitures, partially offset by reductions in operating expenses and lower interest expense.

Insurance segment comparison of the nine months ended September 30, 2026 to the nine months ended September 30, 2025

September 30, 2026 September 30, 2025 Change % Change
Insurance Insurance
Commission income $ 7,780,604 $ 9,818,872 $ (2,038,268 ) -21 %
Total Revenue 7,780,604 9,818,872 (2,038,268 ) -21 %
Total operating expenses
Commission expense 3,192,515 3,454,147 (261,632 ) -8 %
Salaries and wages 2,327,956 3,228,657 (900,701 ) -28 %
General and administrative expenses 796,665 970,902 (174,237 ) -18 %
Marketing and advertising 10,583 42,574 (31,991 ) -75 %
Interest expense 360,743 829,090 (468,347 ) -56 %
Interest expense related parties - 50,377 (50,377 ) -100 %
Insurance Segment Net income $ 1,092,143 $ 1,243,124 $ (150,981 ) -12 %

Insurance segment revenue decreased compared to the prior-year period. Commission Income decreased, primarily attributable to portfolio realignments completed during 2025 and 2026, including the divestitures of Fortman Insurance Services (FIS), Employee Benefits Solutions (EBS), which eliminated commission revenue previously generated by these operations as well as a general decline in certain commissions, offset by certain commission revenue growth.

Total operating expenses decreased overall compared to the prior-year period, primarily reflecting cost reductions associated with the divestiture of certain business operations and ongoing efficiency initiatives.

● Commission expense decreased, primarily attributable to the Company's portfolio realignment initiatives completed during 2025, including the divestiture of Employee Benefits Solutions (EBS) which eliminated commission expense previously incurred by these operations, offset by higher commission rates of our retained businesses due to general market conditions.
● Salaries and wages decreased significantly due to the elimination of personnel costs associated with the divested FIS and EBS businesses.
● General and administrative expenses declined as a result of the agency divestitures and general operational efficiencies.
● Marketing and advertising expenses decreased substantially, consistent with the Company's current marketing strategy.
● Total interest expense (including related party interest) decreased significantly due to the repayment of outstanding loan balances and periodic paydowns of related party obligations.

As a result of the above factors, Insurance segment profitability declined compared to the prior-year period. The decrease was primarily driven by the decline in revenue following the divestitures partially offset by reductions in operating expenses and lower interest expense.

Non-GAAP Reconciliation from Net Income (Loss) to AEBITDA

The following table provides a reconciliation from net income (loss) to consolidated AEBITDA for periods ended September 30, 2026, and September 30, 2025

Three Months Ended September 30, Nine Months Ended September 30,
2026 2025 2026 2025
Net income (loss) $ 3,340,881 $ (1,156,583 ) $ (124,571 ) $ (5,604,367 )
Adjustments:
Interest and related party interest expense 127,399 251,426 378,444 895,657
Depreciation and amortization 216,829 313,694 774,249 1,020,440
Asset Impairments 90,841 - 90,841 -
Share based compensation employees directors and third parties 1,160,813 2,808,446 1,562,707 5,312,988
Other (income) expense, net

-

16,470 - 41,068
Settlement income (70,000 ) - (70,000 ) -
Transactional costs 84,662 61,450 656,391 452,686
Non-standard costs - 23,072 - (12,182 )
Loss from equity method investment - - 120,384 -
Gain on sale of business (7,730,012 ) (3,033,554 ) (7,730,012 ) (3,033,554 )
Loss on extinguishment of debt
117,841 - 117,841
Equity investments impairment loss
713,771 - 713,771 -
Unrealized (gains) losses on digital assets, net - 8,558 (9,263 ) 8,558
Total adjustments $ (5,287,856 ) $ 449,562 $ (3,394,646 ) $ 4,685,661
AEBITDA $ (1,946,975 ) $ (707,021 ) $ (3,519,218 ) $ (918,706 )

Liquidity and capital resources

On July 22, 2026, the SEC approved Nasdaq's adoption of a new continued listing standard requiring listed companies to maintain a minimum Market Value of Listed Securities of $5 million. On July 29, 2026, the approval was stayed following petitions for review, and on September 11, 2026, the SEC granted the petitions and continued the stay pending further review. Accordingly, the new requirement is not currently in effect. Management continues to monitor developments and evaluate alternatives available to maintain compliance with Nasdaq's continued listing requirements.

Overall, the Company continues to maintain flexible access to capital to support its operations and growth initiatives. Management believes that existing cash balances, anticipated operating cash flows, available financing facilities, and access to capital markets, provide sufficient resources to fund current obligations and planned expenditures for at least the next twelve months.

During 2025, the Company further diversified its capital structure through a combination of equity-based financing arrangements, including the Equity Line of Credit ("ELOC") with White Lion Capital, LLC, the At-the-Market ("ATM") Program with H.C. Wainwright & Co., LLC, and the Private Placement-2025 completed in June 2025. During the first quarter of 2026, the Company completed a public offering generating gross proceeds of approximately $2.0 million before offering expenses. These financing vehicles provide the Company with multiple sources of capital that may be accessed opportunistically and at prevailing market prices while maintaining control over timing and issuance levels.

During the nine months ended September 30, 2026, the Company sold 514,496 shares of Common Stock under the ATM Program for net proceeds of approximately $1.7 million. As of September 30, 2026, approximately $184 of Common Stock remained available for issuance under the ATM Program. During the nine months ended September 30, 2026, the Company sold 254,666 shares under the ELOC Agreement for net proceeds of approximately $720,000. As of September 30, 2026, remaining capacity under the facility was approximately $48.3 million. Subsequent to September 30, 2026, we paid $3.0 million in cash at the closing of the Oblivus acquisition and deposited an additional $375,000 in escrow, paid approximately $0.8 million in cash in settlement of certain equity awards and, through LGG, funded an additional $225,000 to Innervate. The ATM Program has been substantially fully utilized. As discussed elsewhere in this Report, including under Part II, Item 1A (Risk Factors), our access to the capital markets and additional financing, including these financing vehicles, is subject to certain risks that may be outside of our control.

Management intends to use the net proceeds from these financings for general corporate purposes, including working capital, technology development, and to advance its growth initiatives. Management continues to evaluate additional financing alternatives and believes that the combination of strengthened balance-sheet metrics, flexible equity facilities, and expected operational cash flows provides adequate liquidity to support both near-term needs and long-term strategic growth objectives.

As of September 30, 2026, we had an unrestricted cash balance of approximately $6.7 million and working capital of approximately $7 million, compared with a combined unrestricted and restricted total cash balance of approximately $2,731,000 and working capital of approximately $1,875,000 as of December 31, 2025.


Inflation

The Company generally may be impacted by rising costs for certain inflation-sensitive operating expenses such as labor, employee benefits, and facility leases. The Company believes inflation could have a material impact on pricing and operating expenses in future periods due to the state of the economy and current inflation rates.

Off-balance sheet arrangements

We did not have any off-balance sheet arrangements, as such term is defined in Regulation S-K, during the nine months ended September 30, 2026.

Cash Flows

Nine Months Ended

September 30,

2026 2025
Net cash used in operating activities $ (3,852,000 ) (1,469,000 )
Net cash provided by investing activities 8,474,000 4,289,000
Net cash used in financing activities (653,000 ) (1,115,000 )
Net increase in cash, cash equivalents, and restricted cash $ 3,968,000 $ 1,706,000

Operating Activities

Net cash used in operating activities for the nine months ended September 30, 2026 was approximately $3,852,000 compared to approximately $1,469,000 for the nine months ended September 30, 2025. Cash used in operating activities for the 2026 period reflects a net loss of approximately $125,000, adjusted for net non-cash items of approximately $4,314,000 that reduced operating cash flows, partially offset by approximately $586,000 of cash provided by changes in operating assets and liabilities. The non-cash adjustments consisted primarily of a gain on sale of businesses of approximately $7,730,000, partially offset by depreciation and amortization of approximately $774,000, equity-based compensation and equity-based payments to third parties of approximately $1,591,000, impairment losses of approximately $805,000, loss on equity method investment of approximately $120,000, and loss on extinguishment of debt of approximately $118,000.

Investing Activities

Net cash provided by investing activities for the nine months ended September 30, 2026 was approximately $8,474,000 compared to approximately $4,289,000 for the nine months ended September 30, 2025. Cash provided by investing activities for the 2026 period consisted primarily of proceeds from sales of businesses of approximately $10,163,000 and proceeds from sales of crypto assets of approximately $118,000, partially offset by equity investments of approximately $1,784,000 and purchases of intangible assets and property and equipment of approximately $24,000.

Financing Activities

Net cash used in financing activities for the nine months ended September 30, 2026 was approximately $653,000 compared to approximately $1,115,000 for the nine months ended September 30, 2025. Cash used in financing activities for the 2026 period consisted primarily of principal repayments of debt of approximately $5,235,000, payments of loans payable to related parties of approximately $287,000, principal repayments of short-term financings of approximately $110,000, and cash paid for deemed dividends of approximately $131,000, partially offset by proceeds of approximately $2,526,000 from common shares issued through a public offering, approximately $1,712,000 from common shares issued through an at-the-market offering, approximately $151,000 from short-term financings, and approximately $720,000 from common shares issued through an equity line of credit.

Significant Accounting Policies and Estimates

We describe our significant accounting policies in Note 1, Summary of Significant Accounting Policies, of the Notes to Consolidated Financial Statements, and our critical accounting estimates in Item 7, Management's Discussion and Analysis of Financial Condition and Results of Operations, in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025. There have been no significant changes in our significant accounting policies or critical accounting estimates since the end of fiscal year 2025.

Reliance Global Group Inc. published this content on November 16, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on November 16, 2026 at 22:19 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]